Edition:
United States

Xenetic Biosciences Inc (XBIO.OQ)

XBIO.OQ on NASDAQ Stock Exchange Capital Market

2.70USD
19 Oct 2018
Change (% chg)

-- (--)
Prev Close
$2.70
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
128,384
52-wk High
$8.94
52-wk Low
$1.45

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.00 -0.232
Mar '18 0.00 -0.209
FY 2017 Dec '17 7.50 0.510
Sep '17 0.09 -0.259
Jun '17 0.00 -0.335
Mar '17 0.00 -0.336
FY 2016 Dec '16 3.00 -0.532
Sep '16 0.00 -0.275
Jun '16 0.00 -6.121
Mar '16 0.00 -0.778
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 119.85 32.14
P/E High - Last 5 Yrs. -- 284.29 46.82
P/E Low - Last 5 Yrs. -- 95.75 24.71
Beta 0.84 0.63 0.87
Price to Sales (TTM) 3.01 109.82 6.55
Price to Book (MRQ) 1.79 13.72 4.00
Price to Tangible Book (MRQ) 88.50 20.21 6.10
Price to Cash Flow (TTM) -- 69.50 21.51
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.35 1.68
Dividend Yield - 5 Year Avg -- 0.20 1.45
Dividend 5 Year Growth Rate -- 2.61 -5.91
Payout Ratio(TTM) -- 5.68 46.77

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 157.56 7.91
Sales (TTM) vs TTM 1 Yr. Ago 152.83 91.25 6.56
Sales - 5 Yr. Growth Rate -- 25.47 7.49
EPS (MRQ) vs Qtr. 1 Yr. Ago 30.91 297.15 26.63
EPS (TTM) vs TTM 1 Yr. Ago 87.18 -- --
EPS - 5 Yr. Growth Rate -- 25.12 7.65
Capital Spending - 5 Yr. Growth Rate -- 39.11 8.16

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.65 2.22
Current Ratio (MRQ) 2.57 5.52 2.99
LT Debt to Equity (MRQ) 0.00 15.33 11.31
Total Debt to Equity (MRQ) 0.00 18.80 14.15
Interest Coverage (TTM) -53.08 -216.32 34.46

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 98.72 32.64 54.36
Gross Margin - 5 Yr. Avg. -- 52.76 53.16
EBITD Margin (TTM) -21.22 -- --
EBITD - 5 Yr. Avg -- -164.07 16.13
Operating Margin (TTM) -21.51 -618.88 3.36
Operating Margin - 5 Yr. Avg. -- -178.92 11.28
Pre-Tax Margin (TTM) -21.88 -615.68 3.79
Pre-Tax Margin - 5 Yr. Avg. -- -181.48 11.54
Net Profit Margin (TTM) -21.88 -604.79 0.60
Net Profit Margin - 5 Yr. Avg. -- -179.91 7.83
Effective Tax Rate (TTM) -- 11.98 20.73
Effective Tax Rate - 5 Yr. Avg. -- 19.65 24.38

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 24,741,437 725,680,242
Net Income/Employee (TTM) -- 1,102,410 84,001,075
Receivable Turnover (TTM) -- 4.18 5.06
Inventory Turnover (TTM) -- 2.14 3.65
Asset Turnover (TTM) 0.45 0.39 0.82

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -9.85 0.35 9.83
Return on Assets - 5 Yr. Avg. -- 3.11 10.94
Return on Investment (TTM) -11.01 1.96 12.83
Return on Investment - 5 Yr. Avg. -- 2.91 14.05
Return on Equity (TTM) -13.66 1.12 14.95
Return on Equity - 5 Yr. Avg. -- -0.97 15.39
  1 Year 3 Year 5 Year
Sales % 152.83 -- --
EPS (TTM) % 94.71 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Xenetic Biosciences Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 0.59%
# of Holders: 7
Total Shares Held: 55,830
3 Mo. Net Change: 29,968
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 1
# Reduced Positions: 0
# Net Buyers: 1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.